Over half of the world’s population fears harm from drinking water within two years, study reveals

Over half of the global population anticipates harm from drinking water within the next two years, influenced by past experiences, economic status, and government corruption. Addressing these concerns is crucial for improving public trust in water safety.

ATH-1020 by Athira Pharma for Neurodegenerative Diseases: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 28, 2023

Novo Nordisk, Valo to develop cardiometabolic disease therapies

Novo Nordisk will license three preclinical drug discovery programmes developed using Valo’s platform. Credit: Novo Nordisk. Novo Nordisk has signed an agreement with Valo Health for the

September 26, 2023

Mitochondria’s division of labor sheds light on how cancer cells survive harsh conditions

Research shows mitochondria form distinct subpopulations under nutrient stress, revealing survival mechanisms in cancer cells and potential therapeutic targets.

November 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.